Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
J Hosp Infect ; 140: 1-7, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37487794

ABSTRACT

BACKGROUND: Transmission of infections via contaminated endoscopes is a common problem. Manual cleaning, using at least a detergent, is an important step in endoscope processing and should be performed as soon as possible to avoid drying of organic residues that might interfere with high-level disinfection and promote biofilm formation. AIM: To assess the efficacy of two detergent-disinfectants, enzymatic and non-enzymatic, and of an enzymatic detergent used during the manual cleaning against a Klebsiella pneumoniae biofilm. METHODS: A 24 h biofilm statically formed in a Tygon tube was exposed to detergent-disinfectants at 20 °C and 35 °C for 10 mn, and to enzymatic detergent at 45 °C for 60 mn. The logarithmic reduction in bacteria in the Tygon tube and the number of bacteria in the product supernatant were calculated. FINDINGS: Biofilm formation was reproducible between assays. After exposure to detergent-disinfectants, the logarithmic reduction was between 6.32 and 6.71 log10 cfu/cm2 in the Tygon tubes. No bacteria were found in their supernatants. Results in the detergent-disinfectant group were not affected by the exposure temperature or the addition of enzymes. No decrease in the bacterial load was observed in the Tygon tubes after exposure to the enzymatic detergent. Bacteria were found in its supernatant. CONCLUSION: These results show the importance of the choice of products used during the manual cleaning phase. They also show the potential benefit of combining detergent and disinfectant activity to decrease the bacterial load during the manual cleaning step of endoscope processing.


Subject(s)
Disinfectants , Humans , Disinfectants/pharmacology , Klebsiella pneumoniae , Detergents/pharmacology , Disinfection/methods , Endoscopes/microbiology , Biofilms
3.
Eur J Clin Microbiol Infect Dis ; 39(6): 1129-1136, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32006178

ABSTRACT

Biofilm in endoscopes is a major problem that can result in failure of disinfection. We studied the survival of K. pneumoniae in a biofilm formed on endoscope tubes subjected to combined chemical and physical stresses. We monitored bacterial survival in the biofilm after the action of 1% and 2% GTA either immediately or after 15 days of desiccation and described the ability of surviving bacteria to recolonize endoscope tubing in a dynamic model. There were surviving bacteria after 5-min exposure to 2% and 1% GTA. The percentage of survivors after 2% and 1% GTA was greater when the GTA treatment was performed after 15 days of prior desiccation of the biofilm. The survivors were able to recolonize and reform biofilm on abiotic surfaces probably because of the survival of persisters in a viable but non-culturable state in the biofilm. Our findings emphasize that the current guidelines on endoscope reprocessing should be strictly followed but that once constituted the biofilm in endoscope tubing will be very difficult to eradicate with present practices.


Subject(s)
Biofilms/growth & development , Desiccation , Endoscopes/microbiology , Glutaral/pharmacology , Klebsiella pneumoniae/physiology , Biofilms/drug effects , Colony Count, Microbial , Disinfection , Humans , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/growth & development , Microbial Viability , Stress, Physiological
4.
Int J Cardiol ; 220: 82-6, 2016 Oct 01.
Article in English | MEDLINE | ID: mdl-27372049

ABSTRACT

OBJECTIVES: To study valve appearance and the presence of valve disease in a cohort of people living with HIV (PLHIV). DESIGN: A prospective study of PLHIV examined at the cardiology department of the Clermont Ferrand university hospital group (CHU) between January 1, 2012, and December 31, 2014. Were excluded those with a history of infection associated with a possible endocarditis. METHODS: Demographic, medical characteristics and cardiovascular disease risk factors at time of cardiovascular examination and Doppler-echocardiography were recorded and analyzed. RESULTS: In total, 903 PLHIV were examined in the infectious diseases department, 255 of whom were included. These consisted of 67 women (26.3%) and 188 men, of a mean age of 51.2±9.7years, in whom coronary artery disease was diagnosed in 18 patients (7.0%), two women and 16 men, representing a prevalence of 3.0% in females and 8.5% in males. The appearance of the aortic cusps was considered dystrophic in 14.1% of cases (36/255), dysplastic in two cases (0.8%), exhibiting a bicuspid deformity in one case. The prevalence of aortic valve abnormality was therefore 6.0% in the women (4/67) and 17.0% in the men (32/188). On facing off this data with the Kora Monica study findings, an increase in prevalence appears only to truly manifest after 50years of age. We registered 35 aortic insufficiency cases (13.7%), representing a higher incidence than that of the Framingham cohort, with age and masculine gender being the determining factors. CONCLUSION: Valve disease, along with coronary artery disease, should be closely monitored in PLHIV.


Subject(s)
Aortic Valve Insufficiency/diagnostic imaging , Aortic Valve Insufficiency/epidemiology , Cardiology Service, Hospital/trends , HIV Infections/diagnostic imaging , HIV Infections/epidemiology , Adult , Cohort Studies , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prevalence , Prospective Studies
5.
Med Mal Infect ; 46(1): 32-8, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26778362

ABSTRACT

OBJECTIVE: We aimed to study factors associated with the outcome of totally implantable venous-access port (TIVAP)-related infections. PATIENTS AND METHODS: We conducted a prospective and observational cohort study of patients presenting with a solid tumor and TIVAP-related infection. RESULTS: We monitored 97 patients for 12weeks. The case fatality at 12weeks was high (54%). Factors associated with case fatality at week 12 included patients' underlying cancer (metastatic status, parenteral nutrition, home care). Infectious complications (local abscess, hematogenous metastases, infection recurrence, septic shock) were frequently observed (48%). The delay in TIVAP removal was the only variable significantly associated with complications (TIVAP removed more than a week after removal decision, P=0.001, or more than a week after onset of clinical symptoms, P=0.002). On the basis of IDSA guidelines, we also observed that 25% of patients whose TIVAP had been removed could have benefited from a conservative treatment. Infections occurring within a month of TIVAP implantation were significantly associated with a Staphylococcus aureus infection (P=0.008). CONCLUSION: Case fatality is high in this population of patients due to the poor status of patients. TIVAP should be promptly removed when appropriate but the patient's poor status might delay or even prevent its removal. Some patients could instead benefit from a conservative treatment. There is currently no recommendation for this therapeutic option and studies are needed to clarify its efficacy. Additionally, infection occurring within a month of TIVAP insertion could be a supplementary criterion for removal as S. aureus is associated with early infection.


Subject(s)
Bacteremia/epidemiology , Catheter-Related Infections/epidemiology , Catheters, Indwelling/adverse effects , Cross Infection/epidemiology , Device Removal , Vascular Access Devices/adverse effects , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Bacteremia/etiology , Catheter-Related Infections/drug therapy , Catheter-Related Infections/etiology , Catheters, Indwelling/microbiology , Cross Infection/drug therapy , Cross Infection/etiology , Equipment Contamination , Female , France , Hospital Mortality , Hospitals, General/statistics & numerical data , Hospitals, University/statistics & numerical data , Humans , Male , Middle Aged , Neoplasms/complications , Neoplasms/mortality , Neoplasms/therapy , Prospective Studies , Sepsis/drug therapy , Sepsis/epidemiology , Sepsis/etiology , Tertiary Care Centers/statistics & numerical data , Time Factors , Treatment Outcome
6.
Eur J Clin Microbiol Infect Dis ; 33(10): 1757-62, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24816900

ABSTRACT

The first French outbreak of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) USA300 clone was investigated. After outbreak investigation, hygiene measures were implemented in all family households and childminders' homes. Several decontamination procedures were performed, which used a combination of topical mupirocin, total body application of chlorhexidine, chlorhexidine gargle (if >6 years old) and a course of antibiotic therapy in cases of infection or decontamination failure. Patients were followed up for MRSA skin and soft tissue infections (SSTIs) and carriage. Strains were characterised by antimicrobial drug resistance profile, pulsed-field gel electrophoresis (PFGE) and DNA microarrays. Between June 2011 and June 2012, six children and six adults among the ten corresponding relatives developed 28 SSTIs. None of the family members, including the index case, had any contact with foreigners or individuals known to have SSTIs. After infection control measures and prolonged decontamination have been implemented with a high adherence, six patients remained sustained CA-MRSA USA300 carriers, including one who developed mupirocin resistance and six who experienced minor CA-MRSA-related SSTIs. A baby was identified as an MRSA carrier 2 months after delivery. CA-MRSA decontamination using mupirocin and chlorhexidine in the community setting may also be a questionable strategy, associated with failure and resistance to both agents. Close monitoring of CA-MRSA SSTIs is required in France and in other European countries where MRSA USA300 has recently emerged. We showed that a closed management based on hygiene measures reinforcement, decolonisation and extended screening may fail to suppress CA-MRSA carriage and subsequent infections.


Subject(s)
Carrier State/epidemiology , Community-Acquired Infections/epidemiology , Disease Outbreaks , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Staphylococcal Skin Infections/epidemiology , Administration, Topical , Adult , Anti-Bacterial Agents/pharmacology , Carrier State/drug therapy , Carrier State/microbiology , Child, Preschool , Chlorhexidine/administration & dosage , Community-Acquired Infections/drug therapy , Community-Acquired Infections/microbiology , Electrophoresis, Gel, Pulsed-Field , Female , Follow-Up Studies , France/epidemiology , Genotype , Humans , Infant , Male , Methicillin-Resistant Staphylococcus aureus/classification , Methicillin-Resistant Staphylococcus aureus/genetics , Microarray Analysis , Middle Aged , Molecular Typing , Mupirocin/administration & dosage , Retrospective Studies , Staphylococcal Skin Infections/drug therapy , Staphylococcal Skin Infections/microbiology , Young Adult
7.
J Mycol Med ; 23(4): 265-9, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24139734

ABSTRACT

Mucormycoses are rare but emerging diseases with poor prognosis caused by ubiquitous fungi from the environment. In November 2008, our teaching hospital experienced three cutaneous mucormycosis due to Lichtheimia spp. (ex Absidia/Mycocladus) in the intensive care and orthopaedic units. Environmental and epidemiological investigations suggested a possible cross-transmission of L. ramosa between two patients in intensive care. This is the first report of possible person-to-person transmission of mucormycosis species. These cases show the ineffectiveness of hydro-alcoholic solutions against spores and underline the need to respect standard precautions to prevent fungi dissemination.


Subject(s)
Cross Infection/microbiology , Dermatomycoses/microbiology , Intensive Care Units , Mucorales/isolation & purification , Mucormycosis/microbiology , Aged , Air Microbiology , Amputation, Surgical , Coinfection , Community-Acquired Infections/microbiology , Cross Infection/transmission , Dermatomycoses/epidemiology , Dermatomycoses/transmission , Foot Injuries/microbiology , Foot Injuries/surgery , Fractures, Open/microbiology , France/epidemiology , Hospitals, Teaching , Humans , Ischemia/complications , Ischemia/surgery , Leg/blood supply , Leg Injuries/microbiology , Leg Injuries/surgery , Male , Middle Aged , Mucormycosis/epidemiology , Mucormycosis/transmission , Mycological Typing Techniques , Operating Rooms , Personnel, Hospital , Postoperative Complications/microbiology , Wound Infection/microbiology , Young Adult
8.
Eur J Clin Microbiol Infect Dis ; 32(2): 199-206, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23079900

ABSTRACT

Vancomycin lock solution (LS) is recommended for the conservative treatment of subcutaneous injection port (SIP)-related infections, but may be associated with failure. We used an in vitro dynamic model of biofilm formation in an SIP, based on a continuous flow circulating via a real SIP, to assess the effectiveness of vancomycin (5 mg/ml), daptomycin (5 mg/ml) and ethanol 40 % LS in eradicating a pre-established Staphylococcus epidermidis biofilm. Heparin, Ringer's lactate and enoxaparin sodium LS were used as controls. The logarithmic reductions of colony-forming units (CFU) were compared by Student's t-test. After 24 h of exposure, the vancomycin LS did not exert a greater bactericidal effect than the heparin LS control (mean logarithmic reduction: 2.27 ± 0.58 vs. 1.34 ± 0.22, respectively, p = 0.3). The mean logarithmic reduction was greater with daptomycin LS (5.45 ± 0.14 vs. 0.39 ± 0.12, p < 0.01) and ethanol LS (6.79 ± 1.03 vs. 1.43 ± 0.54, p = 0.02). Bacterial revival after exposure to 24 h of LS was assessed. The mean viable bacteria count was significantly higher for vancomycin LS (9.36 ± 0.10 log(10)CFU) and daptomycin LS (9.16 ± 0.02 log(10)CFU) than for ethanol LS (2.95 ± 1.65 log(10)CFU). Ethanol appeared to be the most attractive option to treat SIP-related infection, but its poor ability to entirely disrupt the biofilm structure may require its use in association with a dispersal agent to avoid renewal of the biofilm.


Subject(s)
Biofilms/drug effects , Daptomycin/pharmacology , Disinfectants/pharmacology , Disinfection/methods , Equipment and Supplies/microbiology , Ethanol/pharmacology , Staphylococcus epidermidis/physiology , Colony Count, Microbial , Humans , Injections, Subcutaneous/methods , Microbial Viability/drug effects , Staphylococcus epidermidis/drug effects , Vancomycin/pharmacology
9.
Eur Ann Otorhinolaryngol Head Neck Dis ; 129(5): 272-4, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22579632

ABSTRACT

OBJECTIVE: To report a case of bilateral vocal cord abductor paralysis in the context of primary herpes simplex infection. CASE REPORT: A 63-year-old man was urgently admitted to hospital with laryngeal dyspnoea associated with dysphagia but without dysphonia. Physical examination demonstrated the vocal cords in a paramedian position with paralysis of abduction. The patient reported primary herpes simplex infection two weeks prior to this episode. HSV serology indicated recent infection and lumbar puncture demonstrated the presence of herpes simplex virus type 1 in the cerebrospinal fluid. Complete resolution of respiratory symptoms was observed after 21 days of treatment with intravenous aciclovir. DISCUSSION AND CONCLUSION: Gerhardt syndrome comprises inspiratory dyspnoea without dysphonia. It used to be mainly due to syphilis, but is now mostly observed in the setting of neurodegenerative disease. The authors report a case of Gerhardt syndrome occurring after an episode of primary herpes simplex infection with the presence of herpes simplex virus in the CSF. Treatment by intravenous antiviral drugs allowed rapid resolution of the symptoms. The pathophysiology of Gerhardt syndrome remains unexplained, but the possible role of herpes simplex infection should be considered in cases of laryngeal palsy.


Subject(s)
Herpes Simplex/complications , Herpes Simplex/diagnosis , Herpesvirus 1, Human/isolation & purification , Vocal Cord Paralysis/diagnosis , Vocal Cord Paralysis/virology , Acyclovir/administration & dosage , Antiviral Agents/administration & dosage , Follow-Up Studies , Herpes Simplex/cerebrospinal fluid , Herpes Simplex/drug therapy , Humans , Injections, Intravenous , Male , Middle Aged , Time Factors , Treatment Outcome , Vocal Cord Paralysis/drug therapy
10.
J Clin Microbiol ; 50(3): 938-42, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22170930

ABSTRACT

Opinions differ on the value of microbiological testing of endoscopes, which varies according to the technique used. We compared the efficacy on bacterial biofilms of sampling solutions used for the surveillance of the contamination of endoscope channels. To compare efficacy, we used an experimental model of a 48-h Pseudomonas biofilm grown on endoscope internal tubing. Sampling of this experimental biofilm was performed with a Tween 80-lecithin-based solution, saline, and sterile water. We also performed a randomized prospective study during routine clinical practice in our hospital sampling randomly with two different solutions the endoscopes after reprocessing. Biofilm recovery expressed as a logarithmic ratio of bacteria recovered on bacteria initially present in biofilm was significantly more effective with the Tween 80-lecithin-based solution than with saline solution (P = 0.002) and sterile water (P = 0.002). There was no significant difference between saline and sterile water. In the randomized clinical study, the rates of endoscopes that were contaminated with the Tween 80-lecithin-based sampling solution and the saline were 8/25 and 1/25, respectively (P = 0.02), and the mean numbers of bacteria recovered were 281 and 19 CFU/100 ml (P = 0.001), respectively. In conclusion, the efficiency and therefore the value of the monitoring of endoscope reprocessing by microbiological cultures is dependent on the sampling solutions used. A sampling solution with a tensioactive action is more efficient than saline in detecting biofilm contamination of endoscopes.


Subject(s)
Bacteria/growth & development , Bacteria/isolation & purification , Bacteriological Techniques/methods , Biofilms/growth & development , Endoscopes/microbiology , Specimen Handling/methods , Bacterial Load , Hospitals , Humans , Prospective Studies , Random Allocation
11.
Reanimation ; 21(Suppl 2): 503-513, 2012.
Article in French | MEDLINE | ID: mdl-32288729

ABSTRACT

Outbreaks of infectious diseases within healthcare institutions must be detected early and controlled. Hospitals should develop a plan for coordinating all hospital components to respond to these critical situations. The knowledge of the different steps in an outbreak investigation can help identify the source of ongoing outbreaks and prevent additional cases. Outbreak investigation is based on a multidisciplinary approach and is an opportunity for research, training and program considerations.

12.
Endoscopy ; 42(11): 895-9, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20725887

ABSTRACT

BACKGROUND AND STUDY AIMS: Infection is a recognized complication of endoscopic retrograde cholangiopancreatography (ERCP). We describe the epidemiologic and molecular investigations of an outbreak of ERCP-related severe nosocomial infection due to KLEBSIELLA PNEUMONIAE producing extended-spectrum beta-lactamase (ESBL). PATIENTS AND METHODS: We conducted epidemiologic and molecular investigations to identify the source of the outbreak in patients undergoing ERCP. We carried out reviews of the medical and endoscopic charts and microbiological data, practice audits, surveillance cultures of duodenoscopes and environmental sites, and molecular typing of clinical and environmental isolates. RESULTS: Between December 2008 and August 2009, 16 patients were identified post-ERCP with KLEBSIELLA PNEUMONIAE that produced extended-spectrum beta-lactamase type CTX-M-15. There were 8 bloodstream infections, 4 biliary tract infections, and 4 cases of fecal carriage. The microorganism was isolated only from patients who had undergone ERCP. Environmental investigations found no contamination of the washer-disinfectors or the surfaces of the endoscopy rooms. Routine surveillance cultures of endoscopes were repeatedly negative during the outbreak but the epidemic strain was finally isolated from one duodenoscope by flushing and brushing the channels. Molecular typing confirmed the identity of the clinical and environmental strains. Practice audits showed that manual cleaning and drying before storage were insufficient. Strict adherence to reprocessing procedures ended the outbreak. CONCLUSIONS: The endoscopes used for ERCP can act as a reservoir for the emerging ESBL-producing K. PNEUMONIAE. Regular audits to ensure rigorous application of cleaning, high-level disinfection, and drying steps are crucial to avoid contamination.


Subject(s)
Cholangiopancreatography, Endoscopic Retrograde/adverse effects , Disease Outbreaks , Drug Resistance, Multiple, Bacterial , Klebsiella Infections/epidemiology , Klebsiella Infections/transmission , Klebsiella pneumoniae/drug effects , Duodenoscopy/adverse effects , Electrophoresis, Gel, Pulsed-Field , Equipment Contamination , Humans , Klebsiella pneumoniae/genetics , Molecular Typing , beta-Lactamases/analysis
13.
Antibiotiques (Paris) ; 11(1): 29-36, 2009 Feb.
Article in French | MEDLINE | ID: mdl-32288523

ABSTRACT

OBJECTIVES: To describe epidemiological features of viral nosocomial infections (VNI) and their prevention principles. EPIDEMIOLOGY: Many factors lead to underestimate VNI: difficulty to distinguish between community-acquired and nosocomial infections for seasonal viral diseases, incubation time leading to symptoms after patient discharge, difficulty for diagnosis. Population at high risks of VNI are the children, the elderly and the immunocompromized patients. The risk of severe diseases is high in this last population. The main reservoir of virus is infected symptomatic or asymptomatic individuals. Asymptomatic carriers, especially health care workers, are a major source of transmission. Main routes of transmission are the fecal-oral route, the respiratory route, cutaneous or mucous contact and blood and body fluids exposure. A review of the main virus involved in VNI is presented. PREVENTION: Preventive measures, such as strict adherence to standard precautions and, in some instances, to isolation procedures, are critical to control VNI. In a major outbreak situation, it may be necessary to consider cohort isolation. Specific control measures rely on immunization, antiviral drug prophylaxis (varicella-zooster, herpes, influenza, exposure to blood) and clinical and biological screening of organ, blood, tissue and cell donors.

14.
J Water Health ; 6(3): 351-8, 2008 Sep.
Article in English | MEDLINE | ID: mdl-19108555

ABSTRACT

The aim of this study was to assess the presence and seasonal frequency of various enteric viruses in wastewater treatment. The detection of astrovirus, norovirus, enterovirus, hepatitis A virus (HAV) and rotavirus was carried out by molecular analyses in concentrated water samples collected over 18 months at the entrance and exit of an activated sludge sewage treatment plant. The reverse transcriptase-polymerase chain reaction (RT-PCR) results were confirmed by sequencing, and comparative phylogenetic analysis was performed on the isolated strains. Genomes of human astrovirus and human rotavirus were identified in 26/29 and 11/29 samples of raw sewage, respectively, and in 12/29 and 13/29 treated effluent samples, respectively. Some rotavirus sequences detected in environmental samples were very close to those of clinical strains. Noroviruses, enteroviruses and HAV were not detected during the study period. This could be related to the small sample volume, to the sensitivity of the detection methods or to local epidemiological situations. Frequent detection of viral RNA, whether infectious or not, in the exit effluent of sewage treatment indicates wide dispersion of enteric viruses in the environment. Consequently, viral contamination resulting from the use of these treated waters is a risk that needs to be addressed.


Subject(s)
Enterovirus/genetics , Enterovirus/isolation & purification , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis , Sewage/virology , Genotype , Sewage/analysis , Waste Disposal, Fluid , Water Microbiology
15.
Eur J Clin Microbiol Infect Dis ; 27(11): 1061-4, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18612668

ABSTRACT

We describe the control of a hospital-wide vancomycin-resistant Enterococcus faecium (VRE) outbreak in a 2,000-bed university hospital located on three different sites in Clermont-Ferrand, France. From January 2004 to April 2007, 220 VRE cases were identified. Overall, 28 different wards had at least one case. All of the strains expressed a high level of resistance to vancomycin and to teicoplanin carried by the vanA gene. Pulsed-field gel electrophoresis (PFGE) analysis of the strains revealed that they were clonally related. Control measures consisted of implementing a strategy of VRE screening by rectal swab, reinforcing hand hygiene practices and taking contact precautions. Recommendations for a restricted use of specific antibiotics were sent to each physician. Alcohol-based handrubs were provided throughout the hospital and the staff underwent training for their use. Compliance with contact precautions, including the use of clean non-sterile gloves and single-use gowns, was reinforced. VRE cases were assigned systematically to a single-bed room. In October 2007, no new VRE carriage has been detected for 7 months and no clinical samples had been VRE-positive for 10 months. In conclusion, a hospital-wide VRE outbreak was successfully controlled by a strategy based on routine screening, the reinforcement of hand hygiene and taking barrier precautions.


Subject(s)
Cross Infection/epidemiology , Cross Infection/microbiology , Disease Outbreaks , Enterococcus faecium/drug effects , Gram-Positive Bacterial Infections/epidemiology , Gram-Positive Bacterial Infections/microbiology , Vancomycin Resistance , Anti-Bacterial Agents/pharmacology , Bacterial Typing Techniques , Cluster Analysis , DNA Fingerprinting , DNA, Bacterial/genetics , Drug Resistance, Bacterial , Electrophoresis, Gel, Pulsed-Field , Enterococcus faecium/classification , Enterococcus faecium/genetics , Enterococcus faecium/isolation & purification , France/epidemiology , Genotype , Hospitals, University , Humans , Infection Control/methods , Teicoplanin/pharmacology
16.
J Hosp Infect ; 65(1): 47-53, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17141370

ABSTRACT

This paper describes an outbreak of Pseudomonas aeruginosa and Pseudomonas putida that occurred in an oncohaematology paediatric unit between January and April 2005. Eight children had nosocomial infections due to P. aeruginosa (N=5) or P. putida (N=3), which were recovered from central venous catheter blood cultures (N=4), the catheter exit site alone (N=2), or the catheter exit site and the catheter tip (N=2). Subsequent investigation showed that contaminated water outlets represented the possible source of spread. Studies of nursing and environmental cleaning practices revealed two modes of catheter contamination. A reduction in the size of the catheter dressing at the exit site gave less protective cover during showers, and a detergent-disinfectant diluted with tap water had contaminated perfusion bottles. Repetitive intergenic consensus polymerase chain reaction indicated two discrete patterns for P. aeruginosa and one for P. putida. The water network was chlorinated, and disposable seven-day filters were fitted on all taps and showers. Due to the deleterious effects of chlorination on the water network and the cost of the weekly filter change, a water loop producing microbiologically controlled water was installed. In addition, the concentration of the detergent-disinfectant was increased and refillable sprayers were replaced with ready-to-use detergent-disinfectant solution for high-risk areas. Following these measures, no Pseudomonas spp. have since been isolated in clinical or environmental samples from the ward.


Subject(s)
Cross Infection/microbiology , Disease Outbreaks , Pseudomonas Infections/epidemiology , Pseudomonas aeruginosa/pathogenicity , Pseudomonas putida/pathogenicity , Water Purification/methods , Adolescent , Catheters, Indwelling/microbiology , Child , Child, Preschool , Cross Infection/prevention & control , Disease Outbreaks/prevention & control , Environmental Exposure/prevention & control , Environmental Monitoring , Epidemiological Monitoring , Equipment Contamination , France/epidemiology , Humans , Infant , Oncology Service, Hospital , Pediatrics , Pseudomonas Infections/genetics , Pseudomonas Infections/prevention & control , Pseudomonas aeruginosa/genetics , Pseudomonas putida/genetics
17.
Antimicrob Agents Chemother ; 47(9): 2958-61, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12937001

ABSTRACT

In CTX-M-9 extended-spectrum beta-lactamases (ESBLs), an S130G mutation induced a 40- to 650-fold increase in 50% inhibitory concentrations but decreased hydrolytic activity against cefotaxime. A D240K mutation did not modify enzymatic efficiency against ceftazidime. Residue K240 could interact with Q270 and therefore not with ceftazidime, in contrast with what was observed with certain TEM/SHV-type ESBLs.


Subject(s)
Escherichia coli Proteins , beta-Lactamases/genetics , beta-Lactamases/metabolism , Amino Acid Substitution , Anti-Bacterial Agents/pharmacology , Cefotaxime/metabolism , Ceftazidime/pharmacology , Cephalosporins/pharmacology , Hydrolysis , Kinetics , Models, Molecular , Molecular Conformation , Mutation/genetics , Mutation/physiology , Plasmids/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...